Objective To analyze the current status and risk factors of urinary tract infection in patients with chronic kidney disease (CKD). Methods A retrospective study was conducted on 102 patients with CKD admitted to the hospital from July 2022 to June 2025. The incidence of urinary tract infection and distribution characteristics of pathogenic bacteria were investigated. Based on the presence/absence of urinary tract infection, patients were divided into the urinary tract infection group and the non-urinary tract infection group. Clinical data of the two groups were collected and compared. Logistic regression analysis was used to identify risk factors for urinary tract infection in patients with CKD. An evaluation model was established and its efficacy was analyzed using the receiver operating characteristic curve (ROC). Results A total of 32(31.37%) patients developed urinary tract infection. Among the isolated pathogenic bacteria, there were 31(75.61%) strains of Gram-negative bacteria, dominated by Escherichia coli, and 8(19.51%) strains of Gram-positive bacteria, dominated by Enterococcus faecalis. The proportions of patients aged ≥60 years, with diabetes, and with urinary tract obstruction were higher in the urinary tract infection group than in the non-urinary tract infection group (P<0.05). Logistic regression analysis indicated that age (≥60) (OR=4.063, 95%CI: 1.273-12.964), diabetes (OR=11.011, 95%CI: 3.071-39.483), and urinary tract obstruction (OR=17.088, 95%CI: 4.534-64.396) were risk factors for urinary tract infection in patients with CKD (P<0.05). ROC analysis showed that the area under the curve (AUC) of the model constructed based on age, diabetes, and urinary tract obstruction for evaluating urinary tract infection was 0.878(95%CI: 0.812-0.944). The optimal cut-off value, sensitivity and specificity were 0.243, 84.40% and 77.12%, respectively. Conclusion Patients with CKD are at a relatively higher risk of urinary tract infection which is primarily caused by Gram-negative bacteria, especially Escherichia coli. Age ≥60 years, diabetes, and urinary tract obstruction are risk factors, which deserve clinical attention. Screening and intervention for urinary tract infection should be strengthened in patients aged ≥60 years, with diabetes, or with urinary tract obstruction.
Key words
chronic kidney disease /
urinary tract infection /
pathogenic bacteria /
logistic regression /
Escherichia coli /
risk factors
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
[1] 汤文妍, 刘洋, 律海涛. 全民健身政策对慢性肾脏病疾病负担的影响机制: 多国政策工具比较与实证研究[J]. 中国体育科技, 2025, 61(4): 56-68.
[2] 滕玲, 朱长松, 范昊, 等. 司维拉姆治疗对慢性肾脏病患者IL-6、TNF-α及钙磷代谢的影响[J]. 分子诊断与治疗杂志, 2023, 15(8): 1384-1387, 1392.
[3] 钟魏, 申世华, 王韦乐, 等. CKD患者SII、MLR水平与CKD-MBD的相关性研究[J]. 中国基层医药, 2025, 32(6): 841-846.
[4] 黄彩凤, 杨晓帆, 黄正米, 等. 生脉注射液联合局部枸橼酸钠抗凝在接受连续性肾脏替代治疗且伴有高危出血倾向患者中的应用[J]. 西北药学杂志, 2024, 39(6): 189-194.
[5] COUTINHO GMM, SILVA ECD, CAMPANHARO CRV, et al.Urinary tract infection in patients with chronic kidney disease under conservative treatment[J]. Rev Bras Enferm, 2021, 75(3): e20210065.
[6] 王霞, 禹霞, 王萍, 等. 慢性肾脏病患者尿路感染的病原菌分布特征及耐药性分析[J]. 医学临床研究, 2025, 42(12): 2050-2053.
[7] SHANKAR M, NARASIMHAPPA S, MADHURA NS.Urinary tract infection in chronic kidney disease population: a clinical observational study[J]. Cureus, 2021, 13(1): e12486.
[8] 上海市肾内科临床质量控制中心专家组. 慢性肾脏病早期筛查、诊断及防治指南 (2022年版)[J]. 中华肾脏病杂志, 2022, 38(5): 453-464.
[9] 刘长生, 徐志杰. 《EAU泌尿系统感染指南 (2023) 》要点解读[J]. 中华全科医学, 2024, 22(6): 907-914.
[10] ZHANG W, XIU H, CHEN L, et al.Pathogenic bacteria and antimicrobial resistance in hospital-acquired urinary tract infections among patients with diabetic nephropathy[J]. Arch Esp Urol, 2024, 77(7): 779-788.
[11] 王琪, 高兆丽, 吕海琳, 等. 气肿性尿路感染的影响因素及预后分析[J]. 中华肾脏病杂志, 2022, 38(5): 413-419.
[12] 章文, 陈继中, 潘晓龙, 等. 慢性肾功能不全患者尿路感染病原菌及危险因素分析[J]. 国际泌尿系统杂志, 2022, 42(5): 905-909.
[13] 沈丽, 冀婵娟, 常欣, 等. 老年住院患者发生导尿管相关尿路感染的危险因素及临床特点研究[J]. 国际泌尿系统杂志, 2025, 45(1): 91-95.
[14] 钟小晴, 廖康, 王欣, 等. 门诊就诊女性尿路感染患者的尿液病原菌种类及其耐药率分析[J]. 中华妇幼临床医学杂志 (电子版), 2022, 18(2): 185-191.
[15] 陈昕, 陈彤, 李忠发, 等. 老年糖尿病肾病患者尿路感染发生的相关因素[J]. 中国老年学杂志, 2023, 43(15): 3751-3754.
[16] 李艳红, 邹慧兰, 卢曰文, 等. 糖尿病肾病并发泌尿系统感染的病原菌分布特点及相关影响因素分析[J]. 中国病原生物学杂志, 2024, 19(12): 1501-1505.
[17] PISHDAD R, AUWAERTER PG, KALYANI RR.Diabetes, SGLT-2 inhibitors, and urinary tract infection: a review[J]. Curr Diab Rep, 2024, 24(5): 108-117.
[18] 吉娆媛, 吴智明, 云长缨, 等. 糖尿病合并尿道感染患者分离尿道致病性大肠埃希菌毒力因子、耐药性及NLRP3表达[J]. 中华医院感染学杂志, 2023, 33(6): 842-846.
[19] FUKUDA Y, ADACHI S, SAITO M, et al.A rare pathogen Raoultella planticola caused urinary tract infection in child with congenital anomalies of kidney and urinary tract: case report[J]. Transl Pediatr, 2021, 10(9): 2387-2391.
[20] 王荣, 王彩军, 李强. 输尿管结石术后泌尿系统感染患者的血清PCT、TLR4、CRP/ALB变化及预测价值[J]. 国际泌尿系统杂志, 2025, 45(1): 22-26.